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ABSTRACT 
 
Background and objectives: Adjuncts to local anaesthetics for brachial plexus block may enhance the quality and 
duration of analgesia. Dexmedetomidine, a selective α2-adrenoceptor agonist, has been used as an adjuvant during 
regional and local anesthesia. The purpose of this study was to assess the effect of dexmedetomidine added to 
Levobupivacaine  in supraclavicular brachial plexus block. Methods: A prospective, randomized, single blinded 
pilot study  was conducted on 40 ASA I or II adult patients undergoing upper limb orthopaedic surgeries under 
supraclavicular brachial plexus block. Patients were randomly divided into two groups. Patients in Group L(n = 20) 
were administered 29mL of 0.5% Levobupivacaine  plus 1 ml  NS and  group LD (n=20) were given 29 ml of 0.5% 
levobupivacaine with dexmedetomidine 1µg/kg. The onset time and duration of sensory and motor blockade were 
recorded. Results: The onset of sensory and motor block was significantly faster in Group LD compared to Group L 
(P < 0.05). Rescue analgesic requirements were significantly less in Group LD compared to Group  L (P < 0.05). 
Conclusion: Dexmedetomidine(1µg/kg) in combination with 29mL of levobupivacaine (0.5%) hastened onset of 
sensory and motor block . and improved postoperative analgesia when used in brachial plexus block, without 
producing any adverse events. 
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Introduction  
Pain is as old as life. The most humane application of 
chemistry for the solace of mankind has been in the 
discovery of chemical compounds that prevent pain. 
Regional nerve blocks are blocks based on the concept 
that pain is conveyed by nerve fibres which are 
amenable to interruption anywhere along their 
pathway.[1]Supraclavicular brachial plexus block is a 
very popular mode of anaesthesia for various upper 
limb surgeries due to its effectiveness in terms of cost 
and performance, margin of safety and good 
postoperative analgesia.  
  _______________________________ 
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A variety of local anaesthetics and adjuvants have been 
studied for brachial plexus blockade. Levobupivacaine 
is a local anaesthetic drug belonging to amino amide 
group. It is the s.enantiomer of bupivacaine. Previous 
studies have shown levobupivacaine to have a greater 
margin of clinical safety with respect to both CVS 
AND CNS effect compared with racemicbupivacaine 
.[2] Dexmedetomidine is approximately eight times 
more selective towards alpha-2 adrenergic 
receptors.[3]. It has shown to prolong the duration of 
block and post operative analgesia when added to local 
anaesthetics in various regional blocks.[4,5,6]Our 
study evaluates the effects of addition of 
dexmedetomidine to levobupivacaine for 
supraclavicular brachial plexus block in upper limb 
orthopaedic surgery. The effects were studied in terms 
of: 1) Onset of sensory and motor blockade.2) Duration 
of sensory and motor blockade.3)Sedation score intra 
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and post-operatively.4) Haemodynamic variables (HR, 
BP, O2 saturation 5) Number of rescue analgesics in 
post-operative 24 hours.  The above effects were 
compared with that of plain Levobupivacaine (0.5%). 
 
Methodology 
 
After obtaining approval of the ethics committee and 
written informed consent, 40 American Society of 
Anaesthesiologists grade-1 and grade- 2 patients of 
either sex aged 20 to 50 years scheduled for elective 
upper limb orthopedic surgeries e.g., open reduction 
and internal fixation for fracture radius, fracture ulna, 
fracture shaft humerus, under supraclavicular brachial 
plexus block with no prior premedication were 
included in this prospective, randomized, single 
blinded study. Unwilling patients, patients with history 
of allergy to local anaesthetics, infection at local local 
site of block, history of convulsions, bleeding 
disorders, cardiac, respiratory, renal or liver ailment, 
sensory neuropathy and motor deficit in  the arm on 
which surgery is to be performed and patients with 
weighing more than 90kg were excluded from the 
study. The patients were assigned to 2 groups, each 
containing 20 patients. Control group - Group-L which 
received 29 ml Levobupivacaine (0.5%) and 1ml 
normal saline (NS) and the study group - Group LD: 
Received 29 ml of mixture of Levobupivacaine (0.5%) 
and Dexmedetomidine ( 1µ/kg).All patients were 
monitored for anaesthesia and analgesia upto 24 hours 
post-operatively, the sensory block was evaluated by a 
Hollmen scale Score [1] = Normal sensation of 
pinprick; [2] = Weaker sensation of pin prick felt as 
compared with other upper limb; [3] = Pin prick 
recognized as touch with blunt object; [4] = No 
perception of pin prick .The onset and duration of 
sensory loss and motor blockade was studied. The loss 
of pinprick sensation was checked every 3 minutes till 
the onset of loss of sensation and then every ½ hourly 
till the sensations were regained.The motor blockade 
was assessed every 3 minutes till the loss of 
movements and then every ½ hourly till the movements 
are regained. It was evaluated by Modified Bromage 
scale: 
4 Full strength in relevant muscle groups 
3 Strength reduction, but able to move against 
resistance 
2 Ability to move against gravity, but not against 
resistance 
1 Discrete movements (trembling) of muscle groups 
0 Absence of movements 
Onset of sensory block was defined as the time elapsed 
between injection of drug and complete loss of pin 
prick, while onset of motor blockade was defined as 
the time elapsed from injection of drug to complete 
motor block. Sedation score described by University of 
Michigan Sedation Scale (UMSS) was used to assess 
sedation. 1 – Awaked & Alert, 2 – Minimally Sedated: 
tired/sleepy responding to verbal stimulus, 3 – 
Moderately Sedated: somnolent/sleeping, responding to 
mild physical stimulus, 4 – Deeply Sedated: deep 
sleep, responding to moderate to severe physical 
stimulus. 5 – Unarousable.  
Heart rate, non-invasive blood pressure and O2 
saturation were monitored.  Duration of sensory block 
(the time elapsed between injection of drug and 
appearance of pain requiring analgesia) and duration of 
motor block (the time elapsed between injection of 
drug and complete return of muscle power) were 
recorded. Intramuscular injection of Diclofenac sodium 
was given as rescue analgesic when patients 
complained of pain. Number of rescue analgesics in 24 
hours of post-operative period was recorded.  
 
Statistical analysis 
All parameters were analyzed using SPSS version 21 
and STAT 9.0 software. The data among groups were 
compared using unpaired t test.  
 
Results 
 
The minimum age of the patient was 20 years and the 
maximum age was 50 years. The mean age of the 
patients in group L was 32.50 ± 10.440 and in group 
L+D was 35.10 ±8.854. Age incidences between two 
groups were comparable. The mean time for onset of 
sensory block in group L was 13.50 ± 0.607 min, and 
L+D 6.85±0.745 min. The statistical analysis by 
Unpaired t test showed that, the time for onset of 
sensory block in group L+D was significantly faster 
when compared to groupL (P< 0.001). (Table 
1(a)).The mean time for onset of motor block in group 
L+D was 13.25 ± 0.550 min and in group L was 
16.55±0.605. The statistical analysis by Unpaired t test 
showed that, the time for onset of motor block was 
significantly faster in group L+D when compared to 
group L  (P< 0.000). (Table 1(b)).Patients of all two 
groups were observed for 24 hours. Time was noted 
when the patient asked for rescue analgesics. The mean 
duration of sensory block in group L+D was 15.55 ± 
0.605 hours and in group L was 11.10±1.373. The 
statistical analysis by Unpaired t test showed that the 
duration of sensory block in group L+D was 
significantly longer when compared to group L (P < 
0.000). (Table 2(a)).The mean duration of motor block 
in group L+D was 13.85 ± 0.366 hours, and in group L 
was 9.10±1.119 hours. The statistical analysis by 
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Unpaired t test showed that the difference between 
duration of motor block in group LD was significantly 
 
 
Table No. 1(a)
 
Study Group Onset time 
(Mean ± SD) 
L 13.50 ± .607 
L + D 6.85 ± .745 
 
Table No. 1(b)
 
Study Group Onset time 
(Mean ± SD) 
L 16.55 ± .605 
L + D 13.25 ± .550 
 
In group L, the mean pulse rate ranged from 70.50 
5.871 to 77.95 ± 7.141 beats / min. And group L+D,the 
mean pulse rate ranged from 69.50 
 
 
 Fig. 1 (a): Time for Onset of Sensory block
 
Table No. 2(a):
 
Study Group duration time 
(Mean ± SD) 
L 11.10 ± 1.373 
L + D 15.55 ± .605 
 
Table No. 2(b)
Study Group duration time 
(Mean ± SD) 
L 9.10 ± 1.119 
L + D 13.85 ± .366 
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longer when compared to group L (P < 0.000).
2(b)) 
: Time for Onset of Sensory block (In Minutes)
Mean 
difference 
t value p Value 
6.650 30.944 .000 
: Time for Onset of Motor Block (In Minutes)
Mean 
difference 
t value p Value 
3.300 18.051 .000 
± 
± 4.199 to 79.75 ± 
4.723 beats/min.statistical analysis by Unpaired t test 
showed that there was no significant difference in pulse 
rate between the two groups (P > 0.05)
 (Minutes)   Fig. 1(b): Time for Onset of Motor Block (
Time for Duration of Sensory Block (In Hour)
Mean 
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In group L, the mean systolic blood pressure ranged 
from 113.35 ± 9.086 to 119.55 ± 7.149 mmhg. And 
group L+D, the mean systolic blood pressure ranged 
from 110.15± 4.158 to 119.85 ± 4.308 mmhg. 
statistical analysis by student’s unpaired ‘t’ test showed 
that there was no significant difference in systolic 
blood pressure between the two groups (P > 0.05).In 
group L, the mean diastolic blood pressure ranged from 
72.10 ± 5.457 to 76.05 ± 4.904 mm
L+D, the mean diastolic blood pressure ranged from 
70.35 ± 5.480 to 77.30 ± 3.672 mm hg.
analysis by Unpaired t test showed that there was no 
significant difference in diastolic blood pressure 
between the two groups (P > 0.05).In group L, the 
mean O2 saturation ranged from 99.50 
99.95 ± 0.224%. In group L+D the mean O2 saturation 
ranged from 99.50 ± 0.761% to 99.95 ± 0.224%. The 
 
Fig. 2(a): Time for Duration of Sensory Block (
 
Discussion 
 
Scientific confirmation of the cardiac toxicity of 
bupivacaine in 1980s[] stimulated experimental studies 
with its enantiomers, which indicated lower 
cardiopressor activity of S(
(levobupivacaine).[7,8,9,10] Considering the greater 
toxicity potential  and the cardiovascular effects of the 
racemic mixture ,levobupivacaine seems a good 
indication for brachial block. To date, there has been an 
increasing use of some adjuncts (eg, opioids, 
adrenoreceptor agonists) to local anesthetics to 
improve the block quality in peripheral nerve blocks. It 
was suggested in some studies that the addition of 
0
2
4
6
8
10
12
14
16
L L + D 
Duration time
): 148-153                                         e-ISSN: 2349-0659, 
, 2015; 2(2): 148-153
   
 hg. And group 
Statistical 
± 0.761% to 
statistical analysis byUnpaired t test showed that there 
was no significant difference in O2 saturation between 
the two groups (P > 0.05).The total number of rescue 
analgesics used in the form of I/V Diclofenac 75 mg.  
In group L+D, 100% patients required only 1 rescue 
analgesic dosage in post-op 24 hours. In group L
patients required 2 and 25% of patient required 3 
rescue analgesic doses in post
all patients were awake and alert and had sedation 
score of 1. In group L+D 9 patients had score of 1 in 
15min,score 2 in 11 patients in 15 min, In 30min score 
of 1 in 11 patients, score 2 in 9 patients in 30min. and 
in 20 patients had score of 1
patients had sedation score of 3 and above during the 
study period. Statistical analysis of sedation score by 
Chi-square test showed that the difference in sedation 
score was significant (P < 0.05).
Hour)    Fig. 2(b): Time for Duration of Mo
-) bupivacaine 
α2-
α2 agonists to local anesthetics in peripheral nerve 
blocks improved the block quality and extended the 
block duration.[11,12,13,14,15
action of α2-adrenoceptor agonists in peripheral nerve 
blocks is not understood fully.. The most probable 
mechanisms include vasoconstriction, central 
analgesia, and anti-inflammatory effects.
15] Clonidine, the prototype of alpha 2 agonists has 
been synthesized in early 1970.Dexmeditomidine is a 
new alpha 2 agonist that received USFDA approval in 
1999 for use as a short term (less than 24 hrs.)
analgesic in the ICU. alpha  adren
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have different alpha 2/alpha 
1selectivity.Dexmedetomidine is a more 
selective α2 agonist than clonidine. Many studies 
evaluated the effects of dexmedetomidine on 
neuroaxial and peripheral nerve blocks[4,5,13 ]and 
dexmedetomidine was reported to be safe and effective 
in these studies. In a study that compared the effects of 
adding either clonidine or dexmedetomidine to 
lidocaine during a Bier block, it was found that adding 
dexmedetomidine improved the quality of anesthesia 
and analgesia more than the addition of clonidine. In 2 
other studies, a dexmedetomidine–lidocaine mixture 
was used to provide a Bier block and was found to 
improve the quality of anesthesia and reduce 
postoperative analgesic requirement.[5,13] Yoshitomi 
et al., demonstrated that dexmedetomidine as well as 
clonidine enhanced the local anesthetic action of 
lignocaine via peripheral α-2A adrenoceptors. 
[16]Studies by Brummett et al., showed that 
dexmedetomidine enhances duration of bupivacaine 
anesthesia and analgesia of sciatic nerve block in rats 
without any evidence of histopathological damage to 
the nerve. [17,18] In another study, dexmedetomidine 
added to ropivacaine increased the duration of sciatic 
nerve blockade in rats, most likely due to the blockade 
of hyperpolarization-activated cation current (i.e., a 
direcct on the peripheral nerve activity). [19]Bajwa 
et al had compared dexmedetomidine and clonidine in 
epidural anesthesia and concluded that 
dexmedetomidine is a better neuraxial adjuvant 
compared with clonidine for providing an early onset 
of sensory analgesia and prolonged postoperative 
analgesia [20]. Esmaoglu et al evaluateds the effects of 
dexmedetomidine in axillary brachial plexus blocks. 
Esmaoglu et al found that adding dexmedetomidine to 
levobupivacaine for an axillary brachial plexus block 
shortens both the sensory and motor block onset time, 
extends the block duration, and the analgesia 
period.They also indicated that dexmedetomidine may 
lead to bradycardia.  Bradycardia did not occur in our 
study, which is another point on which our study 
differs. We thought that the different results of the 
study by Esmaoglu set al, such as the shortened motor 
block onset time and the occurrence of bradycardia, in 
contrast to those of our study, could be related to their 
use of the higher dexmedetomidine dose of 100 µg in 
all patients.[13]In our study, we compared the effects 
of addition of dexmedetomidine 1µg/kg (Group L+ D) 
to levobupivacaine 0.5%, with the control (group L) in 
supraclavicular brachial plexus block. The result of our 
study shows that all patients in the two groups were 
comparable with respect to demographic profile, 
duration of surgery and type of surgery. With these 
doses, we had stable haemodynamics in patients in all 
the two groups .There was no significant difference in 
pulse rate, mean systolic and mean diastolic blood 
pressure and oxygen saturation in the two groups (p> 
0.05).We also found that onset of sensory block and 
motor block was faster with Group L+ D as compared 
to Group L, was statistically significant. The duration 
of sensory and motor block in Group L+ D was longer 
than Group L, and it was also statistically significant. 
The requirement of rescue analgesic in group L+D was 
lesser than Group L. .None of the patients had sedation 
score of 3 and above during the study period. Statistical 
analysis of sedation score by Chi-square test showed 
that the difference in sedation score was significant (P 
< 0.05).  
 
Conclusion 
 
In our study we found that dexmedetomidine when 
added to levobupivacaine for supraclavicular brachial 
plexus block shortens the onset of sensory and motor 
blockade and prolongs their duration . The  prolonged 
duration of analgesia significantly decreases the need 
for additional analgesics in dexmeditomidine group . 
The added advantage of conscious sedation, 
hemodynamic stability, and minimal side effects makes 
dexmedetomidine a potential adjuvant for nerve blocks. 
Since ours is a pilot study, further studies with large 
sample sizes are warranted to validate these finding. 
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